Fly News Breaks for December 11, 2018
RHHBY
Dec 11, 2018 | 07:55 EDT
Jefferies analyst Peter Welford assumed coverage of Roche with a Buy rating and CHF 300 price target. The analyst is positive on the European large-cap Pharma space "as it enters a period of sustained earnings momentum." He calls Roche his most preferred EU large-cap Pharma name.
News For RHHBY From the Last 2 Days